echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > "The Lancet-Infectious Diseases": HPV vaccine for men reduces related infections by 52%-76%

    "The Lancet-Infectious Diseases": HPV vaccine for men reduces related infections by 52%-76%

    • Last Update: 2021-06-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    ▎Editor of WuXi AppTec's content team Although the impact of the human papillomavirus (HPV) vaccine in women has received widespread attention, in fact, men who are infected with HPV can also develop cancer
    .

    Taking US data as an example, cancers caused by high-risk HPV infection account for 2% of all cancers in men.
    In some countries, men’s HPV vaccination is gradually gaining attention
    .

    A recent study published in The Lancet Infection Disease found that after the implementation of the HPV vaccination program in schools, the probability of men contracting HPV was reduced by 52% to 76%
    .

    Screenshot source: The Lancet Infection Disease official website.
    The study was led by Professor Eric Chow from Monash University.
    The researchers recruited 400 men who had sex with men between 16 and 20 years old in Australia.
    MSM)
    .

    Australia is one of the few countries that has begun to implement HPV vaccination programs for boys and girls at the same time
    .

    The researchers collected anal swabs, penile swabs, and oral rinses from the subjects to test 28 HPV genotypes, and collected population statistics and sexual health behavior data through questionnaires
    .

    By calculating the prevalence rate, corrected age, circumcision, etc.
    , compare the prevalence of HPV before and after vaccination
    .

    The results showed that after the quadrivalent vaccine, the infection rate of anal infections of HPV 6, 11, 16 and 18 decreased from 28% to 7%, and the risk of infection was reduced by 76% (adjusted prevalence ratio PR=0.
    24)
    .

    After being vaccinated with the quadrivalent vaccine, the infection rate of the above four subtypes of penile infection dropped from 12% to 6%, and the risk of infection was reduced by 52% (corrected prevalence ratio PR=0.
    48), but this improvement was mainly caused by HPV6 and 11.
    Type of infection is reduced
    .

    After being vaccinated with the quadrivalent vaccine, the infection rate of the four subtypes of oral infection dropped from 4% to 1%, and there were no cases related to type 6 and type 11 infection
    .

    Compared with before vaccination, the quadrivalent vaccine can prevent anal and penile infections of any HPV genotype targeted by the vaccine, but oral infections are not reduced
    .

    Professor Eric Chow said: "Studies have shown that vaccinating men can effectively reduce related HPV infections and may reduce the incidence of related cancers in the MSM population
    .

    "Related reading "What is the effect of HPV vaccination after being over-aged?" The latest consensus of Chinese application experts: All your doubts are given here for girls of school age to receive HPV vaccination, and China will reduce cervical cancer by 90% in the future! The International Agency for Research on Cancer emphasizes that key populations benefit from HPV How long does the vaccine last? The Lancet sub-published data for more than 10 years: long-term access to antibodies and "extra" cross-protection! How effective is HPV vaccine and screening for cancer prevention? The 17-year big data on 6 cancer types in the United States brings enlightenment | ASCO 2021 Why are some people more likely to get cervical cancer when infected with HPV? A study of 300,000 women in The Lancet-Oncology found new risk factors References: [1] Chow, EP, Tabrizi, SN, Fairley, CK, Wigan, R.
    , Machalek, DA, Garland, SM, .
    .
    .
    & Chen, MY (2021).
    Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study .
    The Lancet Infectious Diseases.
    [2] HPV vaccine shows success in gay, bisexual men.
    Retrieved 2.
    June, from https:// The introduction of medical and health research progress is not a treatment plan recommendation
    .

    If you need treatment plan guidance, please go to a regular hospital for treatment
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.